Side-by-side comparison of AI visibility scores, market position, and capabilities
Zurich AI wearable camera with computer vision for automatic food nutrition logging; YC W23-backed with $450K revenue and $93K+ DROP preorders for Q4 2025 competing for automated fitness nutrition tracking.
rex.fit is a Zürich-based fitness technology company building The DROP — an AI-powered wearable camera that uses computer vision to automatically log food nutrition by photographing meals, track workouts, and generate gamified fitness challenges for health-conscious consumers who want data-driven fitness without manual calorie logging. Founded in 2023 by Ahmad Roumie and Rangel Milushev and backed by Y Combinator (W23), rex.fit generated $450,000 in revenue with a 2-person team and launched The DROP ($199 USD) with $93,000+ in pre-orders (approximately 450 units) targeted for Q4 2025 shipment, establishing a novel computer-vision food tracking wearable in a category dominated by wrist-based fitness trackers.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.